These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 20863736)

  • 1. Role for interferon regulatory factors in autoimmunity.
    Richez C; Barnetche T; Miceli-Richard C; Blanco P; Moreau JF; Rifkin I; Schaeverbeke T
    Joint Bone Spine; 2010 Dec; 77(6):525-31. PubMed ID: 20863736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon regulatory factor 5 in human autoimmunity and murine models of autoimmune disease.
    Eames HL; Corbin AL; Udalova IA
    Transl Res; 2016 Jan; 167(1):167-82. PubMed ID: 26207886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of interferon regulatory factor-mediated signaling in psoriasis.
    Wang WM; Li F; Jin HZ
    Int J Med Sci; 2021; 18(16):3794-3799. PubMed ID: 34790055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon regulatory factor signaling in autoimmune disease.
    Matta B; Song S; Li D; Barnes BJ
    Cytokine; 2017 Oct; 98():15-26. PubMed ID: 28283223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors.
    Honda K; Taniguchi T
    Nat Rev Immunol; 2006 Sep; 6(9):644-58. PubMed ID: 16932750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The IRF family transcription factors at the interface of innate and adaptive immune responses.
    Ikushima H; Negishi H; Taniguchi T
    Cold Spring Harb Symp Quant Biol; 2013; 78():105-16. PubMed ID: 24092468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Innate and intrinsic antiviral immunity in skin.
    Kawamura T; Ogawa Y; Aoki R; Shimada S
    J Dermatol Sci; 2014 Sep; 75(3):159-66. PubMed ID: 24928148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptor signaling and IRF transcription factors.
    Honda K; Taniguchi T
    IUBMB Life; 2006; 58(5-6):290-5. PubMed ID: 16754320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Targeting of IRFs: Pathway-Dependence or Structure-Based?
    Thompson CD; Matta B; Barnes BJ
    Front Immunol; 2018; 9():2622. PubMed ID: 30515152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lyn Kinase Suppresses the Transcriptional Activity of IRF5 in the TLR-MyD88 Pathway to Restrain the Development of Autoimmunity.
    Ban T; Sato GR; Nishiyama A; Akiyama A; Takasuna M; Umehara M; Suzuki S; Ichino M; Matsunaga S; Kimura A; Kimura Y; Yanai H; Miyashita S; Kuromitsu J; Tsukahara K; Yoshimatsu K; Endo I; Yamamoto T; Hirano H; Ryo A; Taniguchi T; Tamura T
    Immunity; 2016 Aug; 45(2):319-32. PubMed ID: 27521268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon regulatory factors: beyond the antiviral response and their link to the development of autoimmune pathology.
    Santana-de Anda K; Gómez-Martín D; Díaz-Zamudio M; Alcocer-Varela J
    Autoimmun Rev; 2011 Dec; 11(2):98-103. PubMed ID: 21872684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic benefits of regulating inflammation in autoimmunity.
    Nikoopour E; Schwartz JA; Singh B
    Inflamm Allergy Drug Targets; 2008 Sep; 7(3):203-10. PubMed ID: 18782028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative regulation of Toll-like-receptor signaling by IRF-4.
    Negishi H; Ohba Y; Yanai H; Takaoka A; Honma K; Yui K; Matsuyama T; Taniguchi T; Honda K
    Proc Natl Acad Sci U S A; 2005 Nov; 102(44):15989-94. PubMed ID: 16236719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of TLR-dependent and independent pathways in autoimmunity].
    Kumagai Y; Akira S
    Nihon Rinsho; 2009 Mar; 67(3):487-93. PubMed ID: 19280921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The critical role of Toll-like receptor signaling pathways in the induction and progression of autoimmune diseases.
    Li M; Zhou Y; Feng G; Su SB
    Curr Mol Med; 2009 Apr; 9(3):365-74. PubMed ID: 19355917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IRF5-mediated immune responses and its implications in immunological disorders.
    Kaur A; Lee LH; Chow SC; Fang CM
    Int Rev Immunol; 2018; 37(5):229-248. PubMed ID: 29985675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The IRF family transcription factors in immunity and oncogenesis.
    Tamura T; Yanai H; Savitsky D; Taniguchi T
    Annu Rev Immunol; 2008; 26():535-84. PubMed ID: 18303999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Interferon Regulatory Factor for Cardiometabolic Diseases: Opportunities and Challenges.
    Zhang Y; Zhang XJ; Li H
    Curr Drug Targets; 2017; 18(15):1754-1778. PubMed ID: 26240052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances and challenges in targeting IRF5, a key regulator of inflammation.
    Almuttaqi H; Udalova IA
    FEBS J; 2019 May; 286(9):1624-1637. PubMed ID: 30199605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptors on the fork roads between innate and adaptive immunity.
    Abdelsadik A; Trad A
    Hum Immunol; 2011 Dec; 72(12):1188-93. PubMed ID: 21920397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.